) --




) hit a new 52-week high Tuesday as it is currently trading at $20.10, above its previous 52-week high of $20 with 324,990 shares traded as of 1:19 p.m. ET. Average volume has been 463,900 shares over the past 30 days.

Medicines has a market cap of $1.02 billion and is part of the

health care

sector and


industry. Shares are up 6.5% year to date as of the close of trading on Monday.

The Medicines Company, a global pharmaceutical company, provides various medicines to hospitals for advancing the treatment of critical care patients primarily in the United States and Europe. The company has a P/E ratio of 7.8, above the average drugs industry P/E ratio of six and below the S&P 500 P/E ratio of 17.7.

  • Sign up for TheStreet's FREE Dividend and Income Investor Newsletter

TheStreet Ratings rates Medicines as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and solid stock price performance. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full

Medicines Ratings Report


See all

52-week high stocks

or get investment ideas from our

investment research center